Literature DB >> 10625071

Mitogen-activated protein kinase is involved in N-methyl-D-aspartate receptor regulation of amyloid precursor protein cleavage.

J Mills1, P B Reiner.   

Abstract

Glutamate is the principal excitatory neurotransmitter in the mammalian brain. Several lines of evidence suggest that glutamatergic hypoactivity exists in the Alzheimer's disease brain, where it may contribute to both brain amyloid burden and cognitive dysfunction. Although metabotropic glutamate receptors have been shown to alter cleavage of the amyloid precursor protein, little attention has been paid to the role of N-methyl-D-aspartate receptors in this process. We now report that activation of N-methyl-D-aspartate receptors in transiently transfected human embryonic kidney 293 cells increases production of the soluble amyloid precursor protein derivative. Moreover, using both pharmacological and gene transfer techniques, we show that this effect is largely due to activation of the mitogen-activated protein kinase cascade, specifically the pathway leading to activation of extracellular signal-regulated protein kinase but not other mitogen-activated protein kinases. These observations further our understanding of the pathways that regulate amyloid precursor protein cleavage, and buttress the notion that regulation of amyloid precursor protein cleavage is critically dependent upon the mitogen-activated protein kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10625071     DOI: 10.1016/s0306-4522(99)00381-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP.

Authors:  Sascha W Weyer; Maja Klevanski; Andrea Delekate; Vootele Voikar; Dorothee Aydin; Meike Hick; Mikhail Filippov; Natalia Drost; Kristin L Schaller; Martina Saar; Miriam A Vogt; Peter Gass; Ayan Samanta; Andres Jäschke; Martin Korte; David P Wolfer; John H Caldwell; Ulrike C Müller
Journal:  EMBO J       Date:  2011-04-26       Impact factor: 11.598

Review 2.  Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Tamar Amit
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

3.  Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition.

Authors:  Max C Richter; Susann Ludewig; Alex Winschel; Tobias Abel; Charlotte Bold; Leonie R Salzburger; Susanne Klein; Kang Han; Sascha W Weyer; Ann-Kristina Fritz; Bodo Laube; David P Wolfer; Christian J Buchholz; Martin Korte; Ulrike C Müller
Journal:  EMBO J       Date:  2018-04-16       Impact factor: 11.598

Review 4.  Not just amyloid: physiological functions of the amyloid precursor protein family.

Authors:  Ulrike C Müller; Thomas Deller; Martin Korte
Journal:  Nat Rev Neurosci       Date:  2017-03-31       Impact factor: 34.870

Review 5.  Amyloid precursor protein processing and Alzheimer's disease.

Authors:  Richard J O'Brien; Philip C Wong
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

6.  Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.

Authors:  Minji Kim; Jaehong Suh; Donna Romano; Mimy H Truong; Kristina Mullin; Basavaraj Hooli; David Norton; Giuseppina Tesco; Kathy Elliott; Steven L Wagner; Robert D Moir; K David Becker; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2009-07-15       Impact factor: 6.150

Review 7.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

8.  S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.

Authors:  Weiping Qin; Lap Ho; Jun Wang; Elaine Peskind; Giulio Maria Pasinetti
Journal:  PLoS One       Date:  2009-01-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.